News

Sanofi granted FDA label expansion for MenQuadfi meningococcal shot for infants
Sanofi (SNY) wins FDA label expansion for its MenQuadfi meningococcal vaccine for use in infants as young as six weeks. Read ...
MedPage Today6d
RFK Jr. Threatens Publishing Ban; Obesity Drug Costs Fall; Nurses' Brain Tumor Probe
HHS Secretary Robert F. Kennedy Jr. threatened to bar NIH scientists from publishing in leading medical journals, saying the ...
Sanofi (SNY)’s MenQuadfi Becomes First MenACWY Vaccine Approved for Ages 6 Weeks and Up
The U.S. FDA has approved an expanded indication for Sanofi (NASDAQ:SNY)’s quadrivalent meningococcal vaccine, MenQuadfi, now ...
US FDA approves use of Sanofi's meningococcal vaccine in infants
French drugmaker Sanofi said the U.S. Food and Drug Administration has approved its meningococcal vaccine for use in infants ...
contemporarypediatrics22d
Frequent perinatal antibiotic use and impaired lung function in preterm-born children
According to the study investigators, led by Ingmar Fortmann, MD, animal models have previously suggested a link between early antibiotic exposure and airway disease. Similar associations have been ...
contemporarypediatrics26d
INF108 to prevent necrotizing enterocolitis receives FDA designations
In a May 7, 2025 announcement, Infinant Health stated that its investigational drug candidate INF108 received both orphan drug and rare pediatric disease designations for the prevention of necrotizing ...
BioSpace29d
FDA Action Alert: GSK, Sanofi, Merck and More
Sanofi Eyes Extension of Meningococcal Disease Shot to Infants, Toddlers Sanofi’s meningococcal disease vaccine MenQuadfi is currently approved for the primary immunization of children aged two years ...